Efficacy and Safety of Tisagenlecleucel in Adult Patients With Refractory or Relapsed Follicular Lymphoma
Clinical trial NCT03568461 · COMPLETED
Trial details
- NCT number
- NCT03568461
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-11-12
- Primary completion
- 2020-11-24
- Enrollment
- 98
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.